Modified dose of guselkumab for treatment of pyoderma gangrenosum.

Publication Title

JAAD Case Rep

Authors

Ashley M Reese
Katherine Erickson, Department of Internal Medicine, Providence Portland Medical Center, Portland, OregonFollow
Katherine B Reed
Alex G Ortega-Loayza

Document Type

Article

Publication Date

3-1-2022

Keywords

oregon; portland; ppmc; DVT, deep venous thrombosis; IL, interleukin; LLE, left lower extremity; PG, pyoderma gangrenosum; biologics (Rx); clinical cases; immunobiologics; leg ulcers; medical dermatology; pyoderma gangrenosum; ulcers; wounds & wound healing

Specialty

Dermatology

Specialty

Internal Medicine

Recommended Citation

Reese, Ashley M; Erickson, Katherine; Reed, Katherine B; and Ortega-Loayza, Alex G, "Modified dose of guselkumab for treatment of pyoderma gangrenosum." (2022). Articles, Abstracts, and Reports. 5893.
https://digitalcommons.providence.org/publications/5893